Artal Group’s Evotec EVO Stock Holding History

Artal Group’s Portfolio EVO Stock Details EVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,149,425	Closed	-$9.3M	–	126
2022 Q4	$9.3M	Hold	1,149,425	–	–	0.52%	45
2022 Q3	$10.1M	Hold	1,149,425	–	–	0.43%	42
2022 Q2	$13.8M	Hold	1,149,425	–	–	0.74%	33
2022 Q1	$17.4M	Hold	1,149,425	–	–	0.73%	32
2021 Q4	$27.3M	Buy	+1,149,425	New	+$26.8M	0.74%	32

Other funds holding EVO

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

DCF Advisers Greenwich, Connecticut $375M AUM 72.65% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artal Group's EVO Position: Q1 2023 in Review

Artal Group sold out of Evotec (EVO) in Q1 2023, closing a stake of 1,149,425 shares — an estimated $9.3M sold.

Artal Group first reported a position in EVO in Q4 2021 and held it in 5 quarters. The position peaked at $27.3M in Q4 2021. 19 funds tracked by Wall St. Rank hold EVO as of Q1 2023.

Artal Group reported no remaining Evotec position as of Q1 2023 after selling out during the quarter.
Artal Group sold 1,149,425 Evotec shares in Q1 2023, an estimated $9.3M.
Artal Group first reported a position in Evotec in Q4 2021 and held it in 5 quarters.
Artal Group's Evotec position peaked at $27.3M in Q4 2021.
19 funds tracked by Wall St. Rank held Evotec as of Q1 2023.

Based on Artal Group's 13F filing for Q1 2023, filed 12 May 2023.